M.D. University of California / Ph.D. Academic Medical Center / Children’s Hospital / King’s College / Never Institute of Child Health Trieste / M.D. New York University Medical Center / HARVARD UNIVERSITY / M.D. Beth Israel Deaconess Medical Center / /
IndustryTerm
noninvasive magnetic resonance imaging / treatment of all patients with Kawasaki disease / therapy for Kawasaki disease / treatment of the acute phase of Kawasaki disease / Treatment of Kawasaki Disease / long-term management / treatment of refractory Kawasaki disease / therapy for primary treatment of Kawasaki disease / noninvasive imaging methods / /
New York University / HARVARD UNIVERSITY / M.P.H. Children’s Hospital Boston / Thomas Jefferson University / Institute of Child Health Trieste / Graduate School / Academic Medical Center / Massachusetts Medical Society / University of California / San Diego / /
Person
Yoshinari Inoue / Gerald F. Greil / Lynn A. Sleeper / Andrea Taddio / D. Rosé / Burns Replies / Arch Dermatol / Jane W. Newburger / Roy G. Geronemus / D. Beth Israel / M.A.M. van der Horst / Warren J. Manning / Menno Huikeshoven / / /
Position
H/T Revised SIZE 16p6 AUTHOR / 1st AUTHOR / Editor / Prime Minister / TITLE EMail Enon ARTIST / /
Product
methylprednisolone / prednisolone / /
ProvinceOrState
New York / Connecticut / Delaware / Massachusetts / /
n e w e ng l a n d j o u r na l The port-wine stains through greater vessel heating and deeper vascular injury.2 The improved technology targets the heterogeneity in blood-vessel